Edition:
United Kingdom

European Commission Approves Amgen, Allergan's Mvasi


Thursday, 18 Jan 2018 

Jan 18 (Reuters) - Amgen Inc ::EUROPEAN COMMISSION APPROVES AMGEN AND ALLERGAN'S MVASI® (BIOSIMILAR BEVACIZUMAB) FOR THE TREATMENT OF CERTAIN TYPES OF CANCER.AMGEN INC - EUROPEAN COMMISSION HAS GRANTED MARKETING AUTHORIZATION FOR MVASI.